April 6, 2011 – The second phase of a trial evaluating the world’s first drug-eluting bioresorbable vascular scaffold ...
April 6, 2011 – A pooled analysis of the SPIRIT II, III, IV and COMPARE trials further reinforces the positive clinical ...
March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows ...
February 25, 2011 – A diagnostic test used to help treat patients with high cholesterol received CE mark approval in ...
January 31, 2011 – A new catheter used to treat coronary artery disease has received regulatory clearance in the United ...
January 27, 2011 – The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices ...
January 20, 2011 – European CE mark approval was granted to expand the indication of Abbott’s Xience Prime everolimus ...
January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting bioresorbable ...
October 13, 2010 – The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it had ...
September 23, 2010 - Results from the second stage of a trial studying a bioresorbable vascular scaffold were announced ...